BioWorld MedTech

Sep. 19, 2012

Aptus snags FDA 510(k) for thoracic-length HeliFX

Aptus Endosystems (Sunnyvale, California), a device company developing technology for endovascular aneurysm repair (EVAR), said it has received FDA 510(k) clearance for its thoracic-length HeliFX Aortic Securement System. Read More

Neovasc upbeat about Tiara preclinical study results

International report: Medical Care Technologies signs MOU with Dragon Link

Washington roundup: MHRA wants more frequent follow-up of St. Jude's Riatas

Financings roundup: Health Care REIT in plan to offer up to 22 million shares

Agreements/contracts: Illumina to provide MiSeq to FDA for genome analysis

HIT roundup: Consumers are beginning to comparison shop healthcare

Med-Tech Notes

People in the News

Product Briefs

FDA approves somo-v ABUS system for dense breast tissue

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...